Caribou Biosciences CRBU
NASDAQ CRBU
$1.22 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Gains from Sales and Divestitures (2020 - 2024)

Updated

Caribou Biosciences' Gains from Sales and Divestitures came in at $25,000 for FY2025, up 177.8% from $9,000 in FY2024.

Analysis

Caribou Biosciences (CRBU) Gains from Sales and Divestitures (2020 - 2024) Analysis & Trends

Going back to FY2019, Caribou Biosciences' Gains from Sales and Divestitures data covers 6 years.

  • The five-year range for annual Gains from Sales and Divestitures is -$4,000 (FY2021) to $34,000 (FY2023).
  • Per Business Quant, earlier years put Gains from Sales and Divestitures at $9,000 in FY2024 (-73.5%), $34,000 in FY2023 and -$4,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Caribou Biosciences 129.31 Mn -387.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 13,000.00
Sep 30, 2024 -4,000.00
Mar 31, 2023 34,000.00
Dec 31, 2021 -1,000.00
Mar 31, 2021 -3,000.00
Sep 30, 2020 -70,000.00
API Access

Caribou Biosciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CRBU&period=max&api_key=YOUR_API_KEY